JERSEY CITY, NJ - A judge has rejected a request for a temporary restraining order (TRO) in the ongoing dispute between CarePoint Health and Hudson Regional Hospital (HRH). The filing, made Thursday by the current operators of Bayonne Medical Center, demanded that HRH stop what the plaintiff called “interference” in the deal that would see BMC Hospital, LLC, take over operations at the more than 100 year old facility.
A spokesperson for HRH said that they were “gratified” with the decision.
In a subsequent statement, HRH officials also said that they were “grateful” for a letter penned by Hudson County Executive Tom DeGise and signed by the mayors of Bayonne, Hoboken, Jersey City, and Union City that requested New Jersey State Health Commissioner Judith Persichilli assist in efforts to preserve acute care services at Bayonne Medical Center, Christ Hospital, and Hoboken University Center.
“Hudson Regional Hospital abides with the County Executive(‘s) calls for this dialogue to be guided by a commitment to transparency and a commitment to Hudson County’s healthcare.
While the statement would appear to put HRH officials in lockstep with county and local officials, the June 5 letter, reviewed by TAPinto, specifically asked the State’s top health official to assist them in obtaining “critical information” related to the possibility of acquiring the facilities through eminent domain, an effort that appears to have been mounted out of concerns that Avery Eisenreich, the current owner of the land, will convert the space into a long-term care facility.
While not speaking directly to the rejection of the TRO, CarePoint officials responded to the ruling by saying that they “welcome the schedule set by the judge and look forward to uncovering the true nature of the back-door dealings between Hudson Regional Hospital and Avery Eisenreich.”
In putting forward a timeline for the case Judge Jeffrey Jablonski ordered a trial date of February 15, 2021.
Know a story we should share with readers? Email editor Steve Lenox and tell him about it.